Scientific paper - Case study
Malignancy Risk in Patient with Neurofibromatosis and Autosomal Dominant Polycystic Kidney Disease
Croatian medical journal, 44 (2003), 4; 485-488. urn:nbn:hr:184:421725


Cite this document

Flego, V., Radojčić Badovinac, A., Pleše, V., Kapović, M., Beg Zec, Z. & Zaputović, L. (2003). Malignancy Risk in Patient with Neurofibromatosis and Autosomal Dominant Polycystic Kidney Disease. Croatian medical journal, 44. (4), 485-488. Retrieved from https://urn.nsk.hr/urn:nbn:hr:184:421725

Flego, Veljko, et al. "Malignancy Risk in Patient with Neurofibromatosis and Autosomal Dominant Polycystic Kidney Disease." Croatian medical journal, vol. 44, no. 4, 2003, pp. 485-488. https://urn.nsk.hr/urn:nbn:hr:184:421725

Flego, Veljko, Anđelka Radojčić Badovinac, Vika Pleše, Miljenko Kapović, Zlata Beg Zec and Luka Zaputović. "Malignancy Risk in Patient with Neurofibromatosis and Autosomal Dominant Polycystic Kidney Disease." Croatian medical journal 44, no. 4 (2003): 485-488. https://urn.nsk.hr/urn:nbn:hr:184:421725

Flego, V., et al. (2003) 'Malignancy Risk in Patient with Neurofibromatosis and Autosomal Dominant Polycystic Kidney Disease', Croatian medical journal, 44(4), pp. 485-488. Available at: https://urn.nsk.hr/urn:nbn:hr:184:421725 (Accessed 02 May 2024)

Flego V, Radojčić Badovinac A, Pleše V, Kapović M, Beg Zec Z, Zaputović L. Malignancy Risk in Patient with Neurofibromatosis and Autosomal Dominant Polycystic Kidney Disease. Croatian medical journal [Internet]. 2003 [cited 2024 May 02];44(4):485-488. Available at: https://urn.nsk.hr/urn:nbn:hr:184:421725

V. Flego, A. Radojčić Badovinac, V. Pleše, M. Kapović, Z. Beg Zec and L. Zaputović, "Malignancy Risk in Patient with Neurofibromatosis and Autosomal Dominant Polycystic Kidney Disease", Croatian medical journal, vol. 44, no. 4, pp. 485-488, 2003. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:421725. [Accessed: 02 May 2024]